• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻微活动后出现呼吸窘迫:一例2019新型冠状病毒(COVID-19)肺炎病例

Respiratory Distress with Minimal Exertion: A Case of 2019 Novel Coronavirus (COVID-19) Pneumonia.

作者信息

Fusco Nicholas, Ganti Latha, Webb Amanda L, Houck Jessica, Kwon Bryan, Lebowitz David

机构信息

University of Central Florida College of Medicine/HCA Healthcare Graduate Medical Education Consortium Emergency Medicine Residency Program of Greater Orlando, Orlando, Florida; Osceola Regional Medical Center, Kissimmee, FL.

Envision Physician Services, Plantation, FL.

出版信息

HCA Healthc J Med. 2020 Nov 28;1:369-372. doi: 10.36518/2689-0216.1120. eCollection 2020.

DOI:10.36518/2689-0216.1120
PMID:37426850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10327976/
Abstract

Description COVID-19 is a new coronavirus that can cause severe respiratory distress. Interestingly, patients can present with COVID-19 and appear relatively well but with significant hypoxia, even with minimal movement. The authors present the case of a well-appearing gentleman who became acutely short of breath while undergoing chest imaging, stating he could not breathe. He tested positive for COVID-19 and recovered. His presentation, clinical course and imaging findings are discussed.

摘要

描述

新型冠状病毒肺炎(COVID-19)是一种可导致严重呼吸窘迫的新型冠状病毒。有趣的是,感染COVID-19的患者可能看起来情况相对良好,但却存在严重缺氧,即使活动极少时也是如此。作者介绍了一位外表状况良好的先生的病例,他在进行胸部成像检查时突然出现呼吸急促,称自己无法呼吸。他的COVID-19检测呈阳性,随后康复。文中讨论了他的临床表现、病程及影像学检查结果。

相似文献

1
Respiratory Distress with Minimal Exertion: A Case of 2019 Novel Coronavirus (COVID-19) Pneumonia.轻微活动后出现呼吸窘迫:一例2019新型冠状病毒(COVID-19)肺炎病例
HCA Healthc J Med. 2020 Nov 28;1:369-372. doi: 10.36518/2689-0216.1120. eCollection 2020.
2
Atypical Chest Computed Tomography Finding of Predominant Interstitial Thickening in a Patient with Coronavirus Disease 2019 (COVID-19) Pneumonia.一名2019冠状病毒病(COVID-19)肺炎患者胸部计算机断层扫描的非典型表现:以间质增厚为主
Am J Case Rep. 2020 Sep 21;21:e926781. doi: 10.12659/AJCR.926781.
3
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.SARS-CoV-2 感染免疫功能低下患者:体液免疫与细胞免疫。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000862.
4
Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.新德里一家三级医疗中心SARI病房中新冠病毒患者的临床和流行病学特征
J Assoc Physicians India. 2020 Jul;68(7):19-26.
5
Bilateral Central Retinal Vein Occlusion in a 40-Year-Old Man with Severe Coronavirus Disease 2019 (COVID-19) Pneumonia.一名患有重症2019冠状病毒病(COVID-19)肺炎的40岁男性双侧视网膜中央静脉阻塞
Am J Case Rep. 2020 Oct 29;21:e927691. doi: 10.12659/AJCR.927691.
6
Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.新冠肺炎合并糖尿病患者极高剂量胰岛素需求:一例报告。
BMC Endocr Disord. 2020 Oct 16;20(1):155. doi: 10.1186/s12902-020-00632-2.
7
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.SARS-CoV2 的神经侵袭性可能在 COVID-19 患者的呼吸衰竭中起作用。
J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
8
A Case of Spontaneous Pneumothorax 21 Days After Diagnosis of Coronavirus Disease 2019 (COVID-19) Pneumonia.1例新型冠状病毒肺炎(COVID-19)确诊后21天出现的自发性气胸病例。
Am J Case Rep. 2020 Aug 15;21:e925787. doi: 10.12659/AJCR.925787.
9
A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.一项评估静脉注射瑞维鲁单抗对比 COVID-19 重症肺炎、急性肺损伤或急性呼吸窘迫综合征患者最佳支持治疗的疗效和安全性的 III 期开放性标签、随机对照研究:一项随机对照试验研究方案的结构性总结。
Trials. 2020 Jul 13;21(1):639. doi: 10.1186/s13063-020-04548-z.
10
Rifampicin-Induced Pneumonitis Mimicking Severe COVID-19 Pneumonia Infection.利福平诱发的肺炎酷似重症新冠病毒肺炎感染
Am J Case Rep. 2020 Aug 25;21:e927586. doi: 10.12659/AJCR.927586.

本文引用的文献

1
White paper on Ivermectin as a potential therapy for COVID-19.关于伊维菌素作为新冠病毒潜在疗法的白皮书。
Indian J Tuberc. 2020 Jul;67(3):448-451. doi: 10.1016/j.ijtb.2020.07.031.
2
Pathological Findings and Management of COVID-19 Patients: A Brief Overview of Modern-day Pandemic.COVID-19患者的病理发现与管理:现代大流行的简要概述
Cureus. 2020 May 15;12(5):e8136. doi: 10.7759/cureus.8136.
3
Novel Coronavirus Disease 2019 and Subarachnoid Hemorrhage: A Case Report.2019年新型冠状病毒病与蛛网膜下腔出血:一例报告
Cureus. 2020 Apr 27;12(4):e7846. doi: 10.7759/cureus.7846.
4
Understanding the Mosaic of COVID-19: A Review of the Ongoing Crisis.了解新冠疫情全貌:对当前危机的综述
Cureus. 2020 Mar 22;12(3):e7366. doi: 10.7759/cureus.7366.
5
Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment.冠状病毒(COVID-19):临床特征、诊断与治疗综述
Cureus. 2020 Mar 21;12(3):e7355. doi: 10.7759/cureus.7355.
6
The Coronavirus Disease 2019 (COVID-19) Pandemic.新型冠状病毒肺炎(COVID-19)疫情。
Tohoku J Exp Med. 2020 Apr;250(4):271-278. doi: 10.1620/tjem.250.271.
7
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.药物治疗 2019 冠状病毒病(COVID-19):综述。
JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019.
8
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.美国食品药品监督管理局批准的药物伊维菌素可抑制 SARS-CoV-2 的体外复制。
Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.
9
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
10
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎的临床、实验室和影像学特征:系统评价和荟萃分析。
Travel Med Infect Dis. 2020 Mar-Apr;34:101623. doi: 10.1016/j.tmaid.2020.101623. Epub 2020 Mar 13.